Ma Jing: Innovate the "prevention, diagnosis, treatment, rehabilitation, and care integration" model

Ma Jing, Director of the Center for Active Health and Translational Medicine of Sichuan Provincial People's Hospital and Initiator of the "Two Cancers" and "Three Early" Active Health Projects for Chinese Women (Photo by Chen Chen)

Recently, under the guidance of the Office of the Healthy China Action Promotion Committee and sponsored by people's daily people's network and people's health, the series of roundtable forums of the 2021 National Two Sessions "Health Chinese" were held in Beijing. On February 28, at the special forum with the theme of "Focusing on Cancer Prevention and Treatment to Help 'Tumor Three Early'", Professor Ma Jing, Director of the Center for Active Health and Translational Medicine of Sichuan Provincial People's Hospital and initiator of the "Two Cancers" and "Three Early" Active Health Project for Chinese Women, said that the screening and prevention process of breast cancer, which is the first cancer incidence among Chinese women and the "two cancers" of cervical cancer in the fourth place, is also a process of continuous innovation and development in the face of various challenges in the diagnosis and treatment of "two cancers" in China.

Ma Jing said that the first major challenge facing China's "two cancers" screening work is the large population base, the difference in the distribution of urban and rural populations, and the financial pressure of the national governments at all levels. In the past ten years or so, the pilot project of "two cancers" for rural women implemented throughout the country has made many achievements and accumulated a lot of experience, and its prevention and treatment has been increasingly valued by local governments and ordinary people. Since 2019, the examination of "two cancers" has been included in the National Basic Public Health Service Project, making it a normal work. Disease screening is actually an organized, large-scale disease prevention and control behavior. It is estimated that at present, there are about 300 million women of the right age for "two cancers" screening in China, and even if only half of this number is achieved, it is a huge challenge for the equalization of basic public health services in China.

"At the same time, the regional differences in 'two cancers' screening in China are also more obvious." Ma Jing said that the regionalization difference between the incidence and death of tumors is obvious, and the incidence of breast cancer in China is the highest in the east and the lowest in the west, and the urban area is higher than that in the countryside. Promoting "two cancers" screening is not the ultimate goal, and the suspicious populations screened out can be further diagnosed and treated, thereby improving the rate of early cancer detection, reducing the incidence of advanced cancer, and ultimately reducing the mortality rate of "two cancers" in China's women. Therefore, it is particularly important to establish regional cancer centers or "two cancers" screening and treatment centers that are tailored to the characteristics of local diseases.

Ma Jing said that there are challenges to innovate. The "three early" breast cancer active health project is not only to investigate and study the current challenges of breast cancer in China in the process of prevention, diagnosis, treatment and health, but also to explore how to respond to these challenges through technological innovation, service model innovation and financing payment method innovation. The project will sort out the past experience and challenges and carry out relevant pilots, and in the pilot process, it will also focus on how various technologies such as AI, big data, and information platform construction can make up for the lack of technical capabilities and information management difficulties of "two cancers" screening in various regions, especially in remote areas.

Nowadays, the industry attaches great importance to service model innovation, but at present, screening and diagnosis and treatment services are still relatively fragmented. Therefore, the service model for the integration of prevention, diagnosis, treatment, rehabilitation and care is more worth exploring. At the same time, Ma Jing proposed that focusing on service model innovation also includes improving payment methods. At present, the basic cost of the "two cancers" screening for rural and urban low-income women in China is provided by the government, and the "two cancers" examination of urban workers will also have unit physical examination benefits, but it is not clear what proportion of women of the right age can be covered. At present, China has also proposed to provide "two cancers" screening services for all women of appropriate age in some regions and cities such as Beijing and Shenzhen. At the same time, although the cost of "two cancers" treatment is responsible for by medical insurance, there are still some urgent problems to be solved in many places for the diagnosis and treatment costs and tracking information management costs of the intermediate group of suspected "two cancers" patients. If the screened suspected population can not be diagnosed and treated in time, the "two cancers" screening can not achieve its ultimate goal, and improve the proportion of early cancer detection, so that it can be treated in time in the best window of disease treatment, its treatment effect is good, the cost is also low, thereby reducing the mortality rate of women in China's "two cancers" and improving the health level of women as a whole. #2021两会 "Health Chinese" #